<--- Back to Details
First PageDocument Content
Immunosuppressants / Cytokines / Amgen / Etanercept / Bioequivalence / Tumor necrosis factor-alpha / Pharmacology / Pharmaceutical sciences / Pharmacokinetics
Immunosuppressants
Cytokines
Amgen
Etanercept
Bioequivalence
Tumor necrosis factor-alpha
Pharmacology
Pharmaceutical sciences
Pharmacokinetics

Clinical Pharmacokinetics Review of BLA[removed]Enbrel, TNFR:Fc) Pharmacokinetic Studies Summary: . -

Add to Reading List

Source URL: www.fda.gov

Download Document from Source Website

File Size: 729,42 KB

Share Document on Facebook

Similar Documents

BIOLOGICS IN THE PRACTICE OF LAW LINDSAY KELLY* Biologics have come to occupy an increasingly important role in the medical industry, accounting for well over $200 billion in worldwide sales inNot surprisingly, bi

BIOLOGICS IN THE PRACTICE OF LAW LINDSAY KELLY* Biologics have come to occupy an increasingly important role in the medical industry, accounting for well over $200 billion in worldwide sales inNot surprisingly, bi

DocID: 1rrNB - View Document

July 15, Bayer Ups Offer to Acquire Monsanto to Approximately $65 Billion Making its first large­scale acquisition since becoming a pure­play life sciences company, Bayer has raised its all­c

July 15, Bayer Ups Offer to Acquire Monsanto to Approximately $65 Billion Making its first large­scale acquisition since becoming a pure­play life sciences company, Bayer has raised its all­c

DocID: 1qiCw - View Document

TABLE OF CONTENTS  INTRODUCTION 2

TABLE OF CONTENTS INTRODUCTION 2

DocID: 1qius - View Document

RHEUMATOLOGY  Rheumatology 2011;50:iv5–iv9 doi:rheumatology/ker241  Indirect and mixed treatment comparisons in arthritis

RHEUMATOLOGY Rheumatology 2011;50:iv5–iv9 doi:rheumatology/ker241 Indirect and mixed treatment comparisons in arthritis

DocID: 1pLt5 - View Document

JUNE 2016 TABLE OF CONTENTS  INTRODUCTION

JUNE 2016 TABLE OF CONTENTS INTRODUCTION

DocID: 1pshE - View Document